Hallmarks of endothelial dysfunction include decreases in the vasodilating and smooth muscle cell antiproliferative molecule NO and increases in the vasoconstricting and proproliferative peptide ET‐1. This evidence concerns the gene EDN1 and endothelial dysfunction.